← Back to Dashboard

AMBUJACEM Ambuja Cements Ltd. — Smart-Money Activity, F&O Buildup & Bulk Deals

Sector: Construction Materials
₹ 434.00
-0.57%
1-year price · range ₹401–₹620

Smart Money Verdict synthesis of derivatives, deals, and promoter files

No significant institutional activity detected
Derivative metrics and institutional flows are quiet. No recent bulk deals or insider disclosures have been reported.

Analysis what the data is telling us about AMBUJACEM

In the last completed session, Ambuja Cements Ltd. closed -0.81% with futures open interest moving +0.4%. Positioning is neutral — neither side is decisively adding or unwinding right now. The stock's option PCR sits at 0.58, indicating heavy call-side writing — option dealers see resistance overhead. Max-pain strike at ₹440 sits 1.4% above the current price, a mild magnet near expiry.

There have been no notable bulk or block deals from FIIs, mutual funds, or insurance companies in Ambuja Cements Ltd. over the last 30 sessions.

Putting it together, the smart-money picture for Ambuja Cements Ltd. lacks a clear directional bias.

F&O Positioning EOD derivatives setup

Buildup Class
Neutral
bias: neutral
Futures OI
86,162,400
+366000 (+0.4%)
Option PCR (OI)
0.58
heavy call writing
Max Pain Strike
₹ 440
writer loss minimized strike

Quote Details key metrics & weights

Previous Close
₹ 436.50
yesterday's EOD close
Index Contribution
not a Nifty 50 constituent
Traded Volume
1,999,701
live shares traded today
Upcoming Earnings
no report scheduled

Technical Snapshot from 400 sessions of price history

RSI (14)
50.3
neutral momentum
52-Week High
₹ 607.95
-28.6% from high
52-Week Low
₹ 394.00
+10.2% above low
200-DMA
₹ 484.46
-10.4% · below trend
50-DMA
₹ 429.00
+1.2% from 50-DMA
1-Year Return
-28.3%
1M +1.4%

Key Fundamentals headline ratios · Basic Materials

P/E (TTM)
24.3
price / earnings
P/B
1.8
price / book
ROE
return on equity
Market Cap
₹ 107,841 Cr
total market value
Dividend Yield
0.46%
trailing yield
EPS (TTM)
₹ 17.85
earnings per share

Fundamental ratios sourced from public market data, refreshed periodically; verify against company filings before relying on them.

Institutional Deals last 30 sessions (bulk & block)

No institutional bulk or block deals recorded for this stock in the last 30 sessions.

Broker Calls as reported · last 120 days

DateBrokerageCallTargetSource
2026-08-03 Nomura Buy ₹500 Moneycontrol.com
2026-08-02 Nomura Buy ₹500 Moneycontrol.com
2026-08-01 Nomura Buy ₹500 Moneycontrol.com
2026-07-31 Nomura Buy ₹500 Moneycontrol.com
2026-07-30 Nomura Buy ₹500 Moneycontrol.com
2026-07-27 Bernstein Upgrade · Outperform NDTV Profit
2026-07-17 Bernstein Upgrade · Outperform NDTV Profit
2026-07-14 Bernstein Upgrade · Outperform NDTV Profit
2026-07-13 Bernstein Upgrade · Outperform NDTV Profit
Analyst calls as reported in the business press — collected and matched by Strota, not recommendations. Targets are the reporting publication's figures.

Insider & Promoter Filings last 60 days

No insider disclosures filed for this stock in the last 60 days.

Option Chain Ladder nearest expiry 2026-08-25 · spot 434 · EOD 2026-08-07

Option writers expect range between 500 and 445+2.5% upside, +15.2% downside.
unbalanced
Call OI (writers) Strike Put OI (writers)
15,600
IV 79% Δ 0.69 θ -0.8 ν 0
405
164,400 +67k
213,600 -414k
IV 31% Δ 0.83 θ -0.3 ν 0
410
853,200 +115k
IV 29% Δ -0.16 θ -0.2 ν 0
70,800 +3k
IV 26% Δ 0.81 θ -0.2 ν 0
415
436,800 +2k
IV 28% Δ -0.20 θ -0.2 ν 0
278,400 +36k
IV 29% Δ 0.72 θ -0.3 ν 0
420
691,200 -14k
IV 28% Δ -0.27 θ -0.2 ν 0
476,400
IV 26% Δ 0.67 θ -0.3 ν 0
425
508,800 +10k
IV 28% Δ -0.34 θ -0.3 ν 0
2,697,600 +30k
IV 29% Δ 0.59 θ -0.3 ν 0
430
958,800 +7k
IV 28% Δ -0.41 θ -0.3 ν 0
529,200 +82k
IV 29% Δ 0.52 θ -0.3 ν 0
435
370,800 -5k
IV 28% Δ -0.48 θ -0.3 ν 0
1,917,600 +147k
IV 28% Δ 0.44 θ -0.3 ν 0
440 MP
708,000 +85k
IV 28% Δ -0.56 θ -0.3 ν 0
2,941,200 +864k
IV 29% Δ 0.37 θ -0.3 ν 0
445 R
526,800
IV 28% Δ -0.63 θ -0.2 ν 0
1,938,000 +13k
IV 29% Δ 0.31 θ -0.3 ν 0
450
604,800 -5k
IV 27% Δ -0.70 θ -0.2 ν 0
288,000 -6k
IV 29% Δ 0.25 θ -0.3 ν 0
455
36,000
IV 25% Δ -0.79 θ -0.1 ν 0
1,412,400 +81k
IV 30% Δ 0.20 θ -0.2 ν 0
460
576,000 -3k
IV 32% Δ -0.78 θ -0.2 ν 0
1,016,400
IV 30% Δ 0.16 θ -0.2 ν 0
465
10,800
IV 66% Δ -0.65 θ -0.6 ν 0

Chain Interpretation

Spot Underlying 434.00
Key Resistance (R) 445
Key Support (S) 500
Max Pain Strike (MP) 440
Concentrations of Option open interest show strong barrier levels. Option writers defend these levels, especially heading into monthly derivatives expiry.

Strategy Builder multi-leg payoff for AMBUJACEM options · 2026-08-25 expiry

Underlying: AMBUJACEM · Spot: ₹ 434.00 · Expiry: 2026-08-25 · Lot: 1200

Legs

Side
Type
Strike
Qty
Premium
Net premium
Max profit
Max loss
Breakevens
Position Delta
Position Theta/day
Position Vega/1% IV

Payoff at expiry

Latest News recent coverage from Reuters, Simply Wall St, MT Newswires and others

AMBUJACEM — frequently asked questions

What is the Ambuja Cements Ltd. share price today?

AMBUJACEM is trading at ₹434.00 (-0.57% vs previous close), per the latest update on this page.

What is the P/E ratio of Ambuja Cements Ltd.?

AMBUJACEM (Ambuja Cements Ltd.) has a trailing twelve-month P/E ratio of 24.3.

What is the market cap of Ambuja Cements Ltd.?

AMBUJACEM has a market capitalisation of approximately ₹107,841 crore.

Is AMBUJACEM near its 52-week high?

AMBUJACEM is trading -28.6% from its 52-week high of ₹607.95 as of 2026-08-07.

What is the RSI of AMBUJACEM?

The 14-day RSI of AMBUJACEM is 50.3, which is considered neutral.

Is AMBUJACEM above its 200-day moving average?

AMBUJACEM is trading below its 200-DMA of ₹484.46 (-10.4% away).

What is the F&O buildup in AMBUJACEM?

The latest end-of-day derivatives data classifies AMBUJACEM as Neutral (bias: neutral), based on the day's combined price and open-interest change.

What is the max pain and PCR for AMBUJACEM options?

AMBUJACEM's option-chain max pain strike is ₹440 and its put-call ratio (OI) is 0.58, from the latest end-of-day option chain.

Are FIIs or big investors buying AMBUJACEM?

Strota tracks every bulk and block deal in AMBUJACEM with named buyers and sellers, plus promoter and insider filings — the tables on this page list the most recent institutional activity as disclosed to the exchanges.

What is the latest broker call on AMBUJACEM?

The most recent analyst call reported in the press is Nomura: Buy with a target of ₹500 (2026-08-03). The Broker Calls section on this page lists reported calls from the last 120 days with links to the original reports.